Morningside House of Spotsylvania was inspected 7 times between January 22, 2021 and May 13, 2026 by the Virginia Department of Social Services. 5 of those visits ended with violations cited and 2 with none. Across that history VDSS cited 13 violations under 11 distinct standards. 1 inspection was prompted by a complaint.
A violation is a licensing standard - a rule in the Virginia Administrative Code - that the inspector found the facility was not meeting. Each is shown with the evidence the inspector recorded and, where VDSS publishes it, the facility's own plan of correction.
VDSS publishes inspections on a rolling window. 5 of these 7 are still on the state's site; the other 2 have since dropped off it and are reproduced from Assisted Living Magazine's archive of the original VDSS reports.
Provider Information
Inspection History
7Select an inspection to read the areas reviewed, the inspector's comments and any violations cited.
May 13, 2026Complaint survey
- September 2025 MAR indicated that resident 1 was not administered their prescribed medication, Gabapentin CV 100 MG (take 1 capsule by mouth every 12 hours) at 8:00 am on 09/15/2025, 09/17/2025, 09/21-22/2025, and 09/29/2025; or 8:00 pm on 09/14-19/2025, 09/21/2025, 09/23-24/2025, 09/26/2025, and 09/28-29/2025.
- During the onsite inspection, 05/13/2026, staff 1 confirmed that resident 1’s Gabapentin CV 100 MG was not administered in accordance with the physician’s or other prescriber’s instructions on the identified dates.
- Post Fall Incident Reports, (02/10/2025, 04/06/2025, 07/04/2025, 08/17/2025, 09/20/2025, 09/24/2025, 10/09/2025, 01/25/2026, and 01/19/2026) indicated that resident 1 sustained multiple witnessed and unwitnessed falls; however, the response to the incidents stated that “no” treatment was provided and/or “no” questions were asked about pain level.
- Resident 1’s individualized service plan (ISP, 01/09/2026) stated, “requires human help with mobility” and “is a fall risk due to cognitive decline and Parkinson’s disease.”
- During the onsite inspection, 05/13/2026, staff 1 acknowledged that resident 1’s documentation indicated a lack of response to falls.
- Resident 1 was prescribed Gabapentin CV 100 MG (take 1 capsule by mouth every 12 hours for pain and neuropathy), 8:00 am and 8:00 pm. September 2025’s Medication Administration Record (MAR) indicated that resident 1 was not administered Gabapentin CV 100 MG at 8:00 am on 09/15/2025, 09/17/2025, 09/21-22/2025, and 09/29/2025; or 8:00 pm on 09/14-19/2025, 09/21/2025, 09/23-24/2025, 09/26/2025, and 09/28-29/2025.
- Medication Management Plan stated, “community will have a Medication Procurement Binder which stores a sheet for each resident who needs to have their outside provider medications managed by our staff. Each shift the Nurse/Medication Aides will review the binder for any outstanding needs or calls to follow up and document as such.”
- During the onsite inspection, 05/13/2026, staff 1 confirmed methods to ensure that resident 1’s Gabapentin CV 100 MG were not followed, which resulted in missed dosages.
May 13, 2026Inspection
- During the onsite inspection conducted on May 13, 2026, Staff 1 provided Resident 1’s current Individualized Service Plan (ISP), dated June 6, 2025; however, the ISP did not include the signature of the resident’s legal representative.
- Staff 1 confirmed that Resident 1’s current ISP, dated June 6, 2025, had not been signed by the resident’s legal representative.
May 13, 2026Inspection
- On March 7, 2026, Staff 1 self-reported to Licensing that Resident 1 missed their prescribed daily dose of Gabapentin 100 mg from February 22, 2026, through March 4, 2026.
- During the onsite inspection conducted on May 13, 2026, a review of Resident 1’s February and March 2026 Medication Administration Records (MAR) indicated that the prescribed Gabapentin 100 mg capsule, ordered to be administered nightly at bedtime, was unavailable for administration from February 15, 2026, through March 4, 2026.
- During the same onsite inspection, Staff 1 provided the facility’s medication management plan, which states: “Community will have a Medication Procurement Binder which stores a sheet for each resident who needs to have their outside provider medications managed by our staff. Each shift the Nurse/Medication Aides will review the binder for any outstanding needs or calls to follow up on and document as such.”
- Staff 1 confirmed that Resident 1 did not receive Gabapentin 100 mg from February 15, 2026, through March 4, 2026, due to staff not adhering to the facility’s medication management plan to ensure timely ordering of the medication, resulting in missed doses for this resident.
- During the onsite inspection conducted on May 13, 2026, a review of Resident 1’s February and March 2026 Medication Administration Records (MAR) indicated that the prescribed Gabapentin 100 mg capsule, ordered to be administered nightly at bedtime, was unavailable for administration from February 15, 2026, through March 4, 2026.
- Resident 1’s Individualized Service Plan (ISP), dated July 22, 2025, and Uniform Assessment Instrument (UAI), dated July 22, 2025, document the resident’s need for assistance with medication administration by facility Licensed Practical Nurse (LPN) or Registered Medication Aide (RMA).
- Staff 1 confirmed that Resident 1’s order for Gabapentin 100 mg to be administered nightly at bedtime was not followed from February 15, 2026, through March 4, 2026, due to the medication being unavailable for administration, resulting in missed doses for the resident.
July 1, 2025Inspection
- During a medication cart audit with staff 2 on 7/2/2025, the LI observed that resident 5’s PRN medication Iprat-Albut .5-3(2.5) MG was not in the medication cart.
- Staff 2 confirmed that Iprat-Albut .5-3(2.5) MG for resident 5 was not in the medication cart.
- During an interview on 7/1/2025, the Licensing Inspector (LI) requested staff 2 provide documentation of completed rounds for any of the 37 residents in care unable to use their signaling device.
- Staff 2 confirmed documentation of rounding for residents with an inability to use the signaling device was not being completed.
- The LI observed during record review on 7/2/2025, that resident 4’s, admitted 6/6/2025, disclosure form was not on the updated form prepared by the department.
- Staff 1 confirmed the disclosure statement in resident 4’s chart was not on the current form prepared by the department.
- During a record review on 7/1/2025 the LI requested a training log for staff 3, hired 2/24/2025, showing completion of 10 hours of training in cognitive impairment.
- Staff 1 confirmed the required documents were not completed and available for review.
- During a record review, on 7/2/2025, the LI requested resident 3’s, admitted 11/7/2024, written assurance.
- Staff 1 confirmed resident 3 did not have the required written assurance available for review.
July 11, 2022Inspection
- Staff F and G had no documentation in the record of a current tuberculosis risk assessment screening. Staff F's last screening was dated April 20, 2020. Staff G's last screening was July 27, 2020.
- Staff C, D and E had no documentation of the original criminal record report.